Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan buys rights to night urination treatment
Yahoo/AP
Friday, April 2, 2010 - 9:07am
tags:
Allergan, night urination, Serenity
The Big Pharma Transparency Report Card: Congratulations, Merck. Lilly? Needs Improvement
BNET Pharma
Friday, April 2, 2010 - 9:06am
tags:
Merck, Eli Lilly, transparency, GSK, Pfizer
Myriad Fallout: Who Are the Winners and Losers in the Gene Patent Ruling?
BNET Pharma
Friday, April 2, 2010 - 9:05am
tags:
Myriad, genes, patents
Boston Scientific in Cash Crunch: Reports
TheStreet.com
Friday, April 2, 2010 - 9:04am
tags:
Boston Scientific
Pfizer Said to Settle Neurontin Suicide Lawsuit for $400,000
Bloomberg
Friday, April 2, 2010 - 9:03am
tags:
Pfizer, Neurontin, suicide, settlements
Off-Label Conditions Take Legal Spotlight
Yahoo/Investors Business Daily
Friday, April 2, 2010 - 9:02am
tags:
off-label, Pfizer, Neurontin
Biotech: Expect Licensing, Not Takeovers
WSJ Online
Thursday, April 1, 2010 - 10:53am
tags:
biotech, liscensing
Human Genome, Gentium in spotlight
Marketwatch
Thursday, April 1, 2010 - 10:47am
tags:
Gentium, Human Genome Sciences
U.S. District Court Rules on Validity of Lilly's Gemzar Patent
Yahoo
Thursday, April 1, 2010 - 10:38am
tags:
Eli Lilly, Gemzar, patents
Healthcare reform driven marketing challenges to “stimulating product interest”
Pharmareform
Thursday, April 1, 2010 - 10:35am
tags:
healthcare reform
Lilly And Sandoz Lose Preemption Argument
Pharmalot
Thursday, April 1, 2010 - 10:30am
tags:
Sandoz, Eli Lilly, Prozac
MDRNA forges $46M merger pact with Cequent
Fierce Biotech
Thursday, April 1, 2010 - 10:28am
tags:
Cequent Pharmaceuticals, MDRNA, M&A
How Gene Patents Harm Innovation
Forbes
Thursday, April 1, 2010 - 10:27am
tags:
genes, Myriad Genetics, patents
Astellas extends offer to buy OSI Pharmaceuticals
Yahoo/AP
Thursday, April 1, 2010 - 10:26am
tags:
Astellas, OSI Pharmaceuticals, M&A
Horizon Therapeutics Said Near Deal to Buy Nitec
Bloomberg
Thursday, April 1, 2010 - 10:11am
tags:
Horizon Therapeutics, Nitec, M&A
What Obamacare Means for GE Healthcare
TheStreet.com
Thursday, April 1, 2010 - 10:08am
tags:
healthcare reform, GE Healthcare
Johnson & Johnson Opens Door to Inventors
TheStreet.com
Thursday, April 1, 2010 - 10:05am
tags:
JNJ, innovation
Depression, Cancer Treatments Boosted Drug Sales 5.1% Last Year
Bloomberg
Thursday, April 1, 2010 - 9:43am
tags:
depression, cancer, prescription data, drug sales
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Bloomberg
Thursday, April 1, 2010 - 9:42am
tags:
Novartis, Orion, Stalevo, prostate cancer, Parkinson's Disease
Sanofi-Aventis settles Eloxatin patent suits
Marketwatch
Thursday, April 1, 2010 - 9:22am
tags:
patents, Eloxatin, Sanofi, settlements

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.